AP2617A - Prevention of HIV-infection - Google Patents

Prevention of HIV-infection

Info

Publication number
AP2617A
AP2617A AP2007004178A AP2007004178A AP2617A AP 2617 A AP2617 A AP 2617A AP 2007004178 A AP2007004178 A AP 2007004178A AP 2007004178 A AP2007004178 A AP 2007004178A AP 2617 A AP2617 A AP 2617A
Authority
AP
ARIPO
Prior art keywords
hiv
infection
prevention
Prior art date
Application number
AP2007004178A
Other languages
English (en)
Other versions
AP2007004178A0 (en
Inventor
Lieven Elvire Colette Baert
Paulus Joannes Lewi
Jan Heeres
Original Assignee
Tibotec Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharmaceutical Ltd filed Critical Tibotec Pharmaceutical Ltd
Publication of AP2007004178A0 publication Critical patent/AP2007004178A0/xx
Application granted granted Critical
Publication of AP2617A publication Critical patent/AP2617A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AP2007004178A 2005-04-04 2006-04-04 Prevention of HIV-infection AP2617A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05102616 2005-04-04
PCT/EP2006/061303 WO2006106103A2 (en) 2005-04-04 2006-04-04 Prevention of hiv- infection with tmc278

Publications (2)

Publication Number Publication Date
AP2007004178A0 AP2007004178A0 (en) 2007-10-31
AP2617A true AP2617A (en) 2013-03-18

Family

ID=34939113

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004178A AP2617A (en) 2005-04-04 2006-04-04 Prevention of HIV-infection

Country Status (29)

Country Link
US (6) US20080194601A1 (xx)
EP (1) EP1881848B1 (xx)
JP (2) JP5632579B2 (xx)
KR (1) KR101360851B1 (xx)
CN (2) CN101155599A (xx)
AP (1) AP2617A (xx)
AR (1) AR053571A1 (xx)
AU (1) AU2006231585B2 (xx)
BR (1) BRPI0607649B8 (xx)
CA (1) CA2602231C (xx)
CY (1) CY1113950T1 (xx)
DK (1) DK1881848T3 (xx)
EA (1) EA011420B1 (xx)
ES (1) ES2402864T3 (xx)
HK (2) HK1117039A1 (xx)
HR (1) HRP20130296T1 (xx)
IL (1) IL184744A (xx)
ME (1) ME01517B (xx)
MX (1) MX2007012277A (xx)
MY (1) MY150091A (xx)
NZ (1) NZ556659A (xx)
PL (1) PL1881848T3 (xx)
PT (1) PT1881848E (xx)
RS (1) RS52724B (xx)
SI (1) SI1881848T1 (xx)
TW (2) TWI457136B (xx)
UA (1) UA90124C2 (xx)
WO (1) WO2006106103A2 (xx)
ZA (1) ZA200708454B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY169670A (en) 2003-09-03 2019-05-08 Tibotec Pharm Ltd Combinations of a pyrimidine containing nnrti with rt inhibitors
TWI457136B (zh) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
EA014914B1 (ru) * 2006-01-20 2011-02-28 Тиботек Фармасьютикалз Лтд. Долговременное лечение вич-инфекции
CN101478950B (zh) * 2006-06-23 2013-02-06 泰博特克药品有限公司 Tmc278的水性悬浮液
CL2008000746A1 (es) 2007-03-14 2008-09-22 Tibotec Pharm Ltd Composicion farmaceutica en solucion que comprende tmc278 y un polimero soluble en agua; proceso de preparacion de dicha composicion; y uso de un polvo que comprende tmc278 para tratar sida.
NZ593950A (en) 2008-12-24 2013-08-30 Janssen R & D Ireland Implantable devices for treating hiv
UA112155C2 (uk) * 2009-12-21 2016-08-10 ЯНССЕН САЙЄНСІЗ АЙРЛЕНД ЮСі Розкладаний видалюваний імплантат для безперервного вивільнення активної сполуки
DE102011082871A1 (de) * 2011-09-16 2013-03-21 Florian, Prof. Dr. Lang Therapeutische und diagnostische Targets für Autoimmunität, inflammatorische Prozesse und/oder immuner Pathogenese und/oder von Erkrankungen, welche auf Autoimmunität, inflammatorische Prozessen und/oder immuner Pathogenese beruhen
JO3387B1 (ar) 2011-12-16 2019-03-13 Glaxosmithkline Llc مشتقات بيتولين
SG10201704467SA (en) 2012-12-14 2017-06-29 Glaxosmithkline Llc Pharmaceutical compositions
MX2017003928A (es) * 2014-09-26 2017-06-28 Glaxosmithkline Intellectual Property (No 2) Ltd Composiciones farmaceuticas de accion prolongada.
WO2022079739A1 (en) 2020-10-14 2022-04-21 Cipla Limited Fixed dose compositions of cabotegravir and rilpivirine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005021001A1 (en) * 2003-09-03 2005-03-10 Tibotec Pharmaceuticals Ltd. Combinations of a pyrimidine containing nnrti with rt inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06316524A (ja) 1992-09-11 1994-11-15 Naoyuki Inoue 抗エイズウイルス剤
US6258932B1 (en) 1999-08-09 2001-07-10 Tripep Ab Peptides that block viral infectivity and methods of use thereof
CZ20023003A3 (cs) 2000-03-30 2002-11-13 Bristol-Myers Squibb Company Perličky s trvalým uvolňováním obsahující stavudin
US20040115268A1 (en) * 2000-04-26 2004-06-17 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
DE60313657T2 (de) 2002-11-08 2008-01-03 Smithkline Beecham Corp. Antivirale zusammensetzungen
EP1599217B1 (en) 2002-11-18 2014-04-16 Polaris Group Methods for inhibiting viral replication in vivo
JP5602333B2 (ja) 2003-02-07 2014-10-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｈｉｖ感染の予防のためのピリミジン誘導体
KR20050101221A (ko) 2003-02-21 2005-10-20 트리펩 아베 Ｈｉｖ 복제의 억제를 위한 글리신아미드 유도체
TWI457136B (zh) * 2005-04-04 2014-10-21 Tibotec Pharm Ltd Ｈｉｖ-感染之預防
EA014914B1 (ru) * 2006-01-20 2011-02-28 Тиботек Фармасьютикалз Лтд. Долговременное лечение вич-инфекции
CN101478950B (zh) * 2006-06-23 2013-02-06 泰博特克药品有限公司 Tmc278的水性悬浮液

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005021001A1 (en) * 2003-09-03 2005-03-10 Tibotec Pharmaceuticals Ltd. Combinations of a pyrimidine containing nnrti with rt inhibitors

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JANSSEN P.A. ET AL.: "IN SEARCH OF A NOVEL ANTI-HIV DRUG: MULTIDISCIPLINARY COORDINATION IN THE DISCOVERY OF 4-[[4-[[4-[(1E)-2-CYANOETHENYL]-2,6-DIMETHYLPHENYL]AMINO]-2-PYRIMIDINYL]AMINO]BENZONITRILE (R278474, RILPIVIRINE)" JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, vol. 48, no. 6, 6 November 2004 (2004-11-06), pages 1901-1909, XP008050052, ISSN: 0022-2623, page 1907 *
SUSMAN E.: "Retroviruses and Opportunistic Infections - 12th Conference. 22-25 February 2005, Boston, MA, USA" IDRUGS 2005 UNITED KINGDOM, vol. 8, no. 4, 2005, pages 299-302, XP008051947, ISSN: 1369-7056, page 300, right-hand column, paragraph 2 *

Also Published As

Publication number Publication date
MY150091A (en) 2013-11-29
PL1881848T3 (pl) 2013-06-28
RS52724B (en) 2013-08-30
WO2006106103A3 (en) 2007-06-07
UA90124C2 (ru) 2010-04-12
KR20080009051A (ko) 2008-01-24
PT1881848E (pt) 2013-04-15
ES2402864T3 (es) 2013-05-09
NZ556659A (en) 2012-03-30
AP2007004178A0 (en) 2007-10-31
SI1881848T1 (sl) 2013-05-31
CA2602231A1 (en) 2006-10-12
BRPI0607649A2 (pt) 2009-09-22
AU2006231585A1 (en) 2006-10-12
EP1881848B1 (en) 2013-01-16
HK1117039A1 (en) 2009-01-09
ZA200708454B (en) 2009-03-25
JP2013079275A (ja) 2013-05-02
US10765674B2 (en) 2020-09-08
BRPI0607649B8 (pt) 2021-05-25
ME01517B (me) 2014-04-20
US20160151276A1 (en) 2016-06-02
US20160296519A1 (en) 2016-10-13
MX2007012277A (es) 2007-10-17
TWI457136B (zh) 2014-10-21
US20220071997A1 (en) 2022-03-10
AU2006231585B2 (en) 2012-02-02
BRPI0607649B1 (pt) 2019-08-06
IL184744A (en) 2015-05-31
CY1113950T1 (el) 2016-07-27
DK1881848T3 (da) 2013-04-15
JP2008534651A (ja) 2008-08-28
AR053571A1 (es) 2007-05-09
US20200397783A1 (en) 2020-12-24
KR101360851B1 (ko) 2014-02-11
EP1881848A2 (en) 2008-01-30
EA011420B1 (ru) 2009-02-27
IL184744A0 (en) 2007-12-03
CA2602231C (en) 2014-03-25
TW200709818A (en) 2007-03-16
EA200702169A1 (ru) 2008-02-28
HRP20130296T1 (hr) 2013-04-30
CN101155599A (zh) 2008-04-02
TW201414495A (zh) 2014-04-16
JP5632579B2 (ja) 2014-11-26
HK1198936A1 (en) 2015-06-19
WO2006106103A2 (en) 2006-10-12
US20110077261A1 (en) 2011-03-31
CN103860560A (zh) 2014-06-18
US20080194601A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
AP2617A (en) Prevention of HIV-infection
PL2335782T3 (pl) Zastosowanie kompozycji zawierającej HFCO-1233zd
HK1161122A1 (en) Use of 24-norudca 24-norudca
SI2497780T1 (sl) Spojine, povezane s TDF, in njihovi analogi
EP1912921A4 (en) COMPOUNDS ON TETRAAZAPORPHYRINBASE AND ITS USES
IL185223A0 (en) Compounds and uses thereof
IL186606A0 (en) Compositions and uses of amooranin compounds
EP1931370A4 (en) USE OF DES-ASPARTATE-ANGIOTENSIN I
GB0505511D0 (en) Attack prevention
EP1904113A4 (en) NEUROPROTECTIVE CONNECTION
HK1117880A1 (en) Catch basin
GB0509544D0 (en) Shower protected airer
GB0510013D0 (en) Interaction of SNEV
TJ20050863A (en) The way of narcotism treatment
GB0521272D0 (en) Compounds and uses thereof
GB0514416D0 (en) Compounds and uses thereof
AU306395S (en) Shower
AU306394S (en) Shower
TWM292330U (en) Improvement of bed-chair structure
GB0514423D0 (en) Novel compositions and compounds
GB0522821D0 (en) Basemaster uk/4
TWM291236U (en) Improved structure of bookrack
GB0514471D0 (en) Compounds and their uses
GB0510263D0 (en) Compounds and their uses
GB0515688D0 (en) Compounds and their uses